103 related articles for article (PubMed ID: 14750219)
1. Nelfinavir safe and effective in HIV/HCV patients.
AIDS Patient Care STDS; 2003 Nov; 17(11):602-3. PubMed ID: 14750219
[No Abstract] [Full Text] [Related]
2. Nelfinavir tolerated in HCV patients.
AIDS Patient Care STDS; 2002 Dec; 16(12):617. PubMed ID: 12881882
[No Abstract] [Full Text] [Related]
3. Women's nelfinavir (Viracept) trial.
Vazquez E
Posit Aware; 1997; 8(5):15. PubMed ID: 11364633
[TBL] [Abstract][Full Text] [Related]
4. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
5. Nelfinavir (Viracept).
Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
[No Abstract] [Full Text] [Related]
6. Symptomatic junctional bradycardia after treatment with nelfinavir.
Landovitz RJ; Sax PE
Clin Infect Dis; 1999 Aug; 29(2):449-50. PubMed ID: 10476763
[No Abstract] [Full Text] [Related]
7. Anti-HIV agents. Nelfinavir levels during pregnancy.
TreatmentUpdate; 2004; 16(3):5-6. PubMed ID: 17216835
[No Abstract] [Full Text] [Related]
8. Hepatitis C and PIs.
Albrecht H
AIDS Clin Care; 2001 Oct; 13(10):97. PubMed ID: 11590923
[TBL] [Abstract][Full Text] [Related]
9. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
Rudin C; Burri M; Shen Y; Rode R; Nadal D; ;
Pediatr Infect Dis J; 2008 May; 27(5):431-7. PubMed ID: 18382386
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review.
Robertson SM; Scarsi KK; Postelnick MJ; Lynch P
Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097
[TBL] [Abstract][Full Text] [Related]
12. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).
Schvarcz R; Rudbeck G; Söderdahl G; Ståhle L
Transplantation; 2000 May; 69(10):2194-5. PubMed ID: 10852623
[TBL] [Abstract][Full Text] [Related]
13. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
[No Abstract] [Full Text] [Related]
14. Comparison of regimens as initial therapy for HIV.
Clotet B
N Engl J Med; 2004 Mar; 350(10):1053-4; author reply 1053-4. PubMed ID: 14999120
[No Abstract] [Full Text] [Related]
15. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
17. Nelfinavir access in Canada.
TreatmentUpdate; 1998 Sep; 10(7):6, 8. PubMed ID: 11365783
[TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
Brown LS; Kritz S; Chu M; Madray C
J Subst Abuse Treat; 2006 Jun; 30(4):331-5. PubMed ID: 16716848
[TBL] [Abstract][Full Text] [Related]
19. Bone appetite--using food to boost your Viracept.
Clay PG
Posit Aware; 2003; 14(4):29. PubMed ID: 12951947
[No Abstract] [Full Text] [Related]
20. Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.
Burger DM; Bergshoeff AS; De Groot R; Gibb D; Walker S; Tréluyer JM; Hoetelmans RM;
J Pediatr; 2004 Sep; 145(3):403-5. PubMed ID: 15343199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
